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Abstract The pedunculopontine nucleus (PPN) is com-
posed of neurons with different connectivity patterns that
express different neurochemical markers, display distinct
firing characteristics and are topographically organized in
functional domains across its rostro-caudal axis. Previous
reports have shown that the caudal region of the PPN is
interconnected with motor regions of both the basal ganglia
and brainstem/medulla. The co-distribution of ascending
and descending motor outputs raises the question as to
whether the PPN provides a coordinated or differential
modulation of its targets in the basal ganglia and the
medulla. To address this, we retrogradely labeled neurons
in the two main PPN pathways involved in motor control
and determined whether they project to one or both struc-
tures, their neurochemical phenotype, and their activity in
normal and dopamine depleted rats, as indicated by Egr-1
expression. We show that ascending and descending motor
pathways from the PPN arise largely from separate neurons
that intermingle in the same region of the PPN, but have a
distinct neurochemical composition and are differentially
regulated in the Parkinsonian state. Thus, neurons pro-
jecting to the subthalamic nucleus consist of cholinergic,
calbindin- and calretinin-expressing neurons, and Egr-1 is
upregulated following a 6-hydroxydopamine lesion. In
contrast, a larger proportion of neurons projecting to the
gigantocellular nucleus are cholinergic, none express cal-
bindin and the expression of Egr-1 is not changed by the
dopamine lesion. Our results suggest that ascending and
descending motor connections of the PPN are largely
mediated by different sets of neurons and there are cell
type-specific changes in Parkinsonian rats.
Keywords Brainstem  Locomotion  Subthalamic
nucleus  Reticulospinal neurons  Parkinson’s disease 
Immediate early genes
Introduction
The pedunculopontine nucleus (PPN) is situated in the
brainstem and was originally proposed to be an interface
between the basal ganglia and the spinal cord (Garcia-Rill
1986). Considered as a part of the mesencephalic loco-
motor region (MLR), early experiments in decorticated rats
showed that electrical stimulation of this region and its
surroundings induced a motor response (Skinner et al.
1990), thus providing evidence of its descending control of
locomotion. Tracer studies have shown that the PPN has
descending projections that mainly innervate targets in the
lower brainstem and medulla, including the nucleus retic-
ularis pontis oralis, the gigantocellular nucleus (GiN) and
the medioventral medulla, and then innervate some regions
of the spinal cord (Mitani et al. 1988; Semba et al. 1990;
Rye et al. 1988; Grofova and Keane 1991; Nakamura et al.
1989; Scarnati et al. 2011). These projections have been
implicated in the control of gait and posture.
In addition to the descending projections, neurons of the
PPN provide an extensive ascending axonal innervation of
several neuronal systems across the midbrain and fore-
brain, including the basal ganglia. Among these, the rela-
tionship between the subthalamic nucleus and the PPN
(Nomura et al. 1980; Edley and Graybiel 1983; Hammond
et al. 1983) has recently attracted the attention in clinical
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neuroscience given the proposed roles of both structures in
the pathophysiology of Parkinson’s disease (PD) and their
current use as therapeutic targets for deep brain stimulation
(DBS). The use of DBS in the PPN has suggested its
involvement in the control of gait (Kringelbach et al. 2007;
Thevathasan et al. 2012; Wilcox et al. 2011; Moro et al.
2010), even though this therapy has yielded ambiguous
results (Hamani et al. 2011).
The PPN is composed of three main phenotypes of
neurons, cholinergic, GABAergic and glutamatergic
(Mena-Segovia et al. 2009; Wang and Morales 2009), but
further subgroups have been defined on the basis of the
expression of neurochemical markers (Martinez-Gonzalez
et al. 2012) and electrophysiological properties (Ros et al.
2010). Along with the neuronal heterogeneity, important
topographical differences define the connectivity of PPN
neurons and their functionality (Martinez-Gonzalez et al.
2011). Neurons innervating motor structures are predomi-
nantly situated in the caudal part of the PPN, which raises
the possibility that basal ganglia and medulla receive the
same signal from PPN neurons. Alternatively, ascending
and descending motor projections may be segregated,
arising from different populations of PPN neurons. These
possibilities entail two different scenarios, the first one
consisting of a coordinated activation of upstream and
downstream targets, and the second supports the idea of a
differential motor output where PPN afferents, as well as
local circuitry, play an important part in determining which
pathway is activated.
Using anatomical methods, we characterized the
connectivity of PPN neurons with two key motor struc-
tures from the ascending and descending PPN motor
pathways (STN and GiN) and investigated their neuro-
chemical composition. In addition, we used immuno-
histochemistry to evaluate the product of the immediate
early gene, Egr-1, in control and 6-hydroxydopamine (6-
OHDA)-lesioned rats to determine the regulation of PPN
motor connections in the Parkinsonian state (Beckmann




All animal procedures used in this study were carried out
under the authority of the Animals (Scientific Procedures)
Act, 1986 (UK) and in accordance with the Society for
Neuroscience policy of the use of animals in neuroscience
research. Sprague-Dawley rats (200–300 g) were used for
the tracer injections, 6-OHDA lesions and immunohisto-
chemical analyses.
6-Hydroxydopamine lesions
Unilateral 6-OHDA lesions were carried out under anes-
thesia which was induced and maintained with isoflurane
(Iso, Schering-Plough Ltd., Welwyn Garden City, UK).
The animals were placed in a stereotaxic frame (David
Kopf Instruments) and injected with desipramine (i.p.;
25 mg/kg in 0.9 % NaCl in dH2O; Sigma) 20 min before
the 6-OHDA injections. A small craniotomy was made in
the right hemisphere and 3 ll of a 6-OHDA solution
(3 mg/ml of 6-OHDA hydrochloride salt; dissolved
immediately before use in an ice-cold solution of 0.9 %
NaCl and 0.02 % ascorbic acid in dH2O; Sigma) was
injected (10 ll syringe; Hamilton 701RN; HA-763501;
Jaytee Biosciences Ltd., Herne Bay, Kent, UK) into the
medial forebrain bundle at the following co-ordinates:
4.5 mm posterior to Bregma, 1.3 mm lateral to Bregma and
7.9 mm ventral to the dura. Injections were carried out with
the aid of a micropump at a rate of 0.5 ll/min. The syringe
was left in place for 5 min before and after the injections
and then slowly withdrawn.
The extent of the 6-OHDA lesion was assessed
14–15 days after the injection by challenge with a subcu-
taneous injection of apomorphine (0.05 mg/kg; 0.9 %
NaCl, Sigma). A lesion was considered successful in ani-
mals that made 80 or more contraversive rotations in
20 min in response to the apomorphine injection. Only
animals with successful lesions were subsequently used for
this study. Typically 1 day after the apomorphine test,
animals were injected with retrograde tracers into the STN
and GiN.
Tracer injections
Fluorescently labeled red and green retrobeads (red ret-
robeads: 530 nm excitation and 590 nm emission wave-
lengths; green retrobeads IX; 460 nm excitation and
505 nm emission wavelengths; Lumafluor, Inc, Durham
NC, USA) were injected into the STN or GiN, respectively,
of control and 6-OHDA-lesioned animals. Anesthesia was
induced using 4 % isoflurane in O2 and maintained during
surgery using an average of 2 % isoflurane (Iso, Schering-
Plough Ltd., Welwyn Garden City, UK). The animals were
placed in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA), a small craniotomy was made above
the STN (3.7 mm posterior to Bregma, 2.6 mm lateral to
Bregma and 7.6 mm ventral to the dura) and 100 nl of red
retrobeads were injected in the STN (1 ll syringe, 70 mm
long; SGE, World Precision Instruments, Stevenage, UK).
After withdrawal of the syringe, a second small craniotomy
was made above the GiN (10.5 mm posterior to Bregma,
0.9 mm lateral to Bregma and 9.5 mm ventral to the dura),
into which 150 nl of green retrobeads were injected. The
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syringe was left in place for 5 min before and after the
injections and then withdrawn.
After 2 weeks of tracer injections, the animals were
perfuse-fixed at the beginning of the dark phase of the
12:12 h light/dark cycle. They were deeply anesthetized
using a mixture of ketamine (30 mg/kg, i.p.; Ketaset,
Willow Francis, Crawley, UK) and xylazine (3 mg/kg, i.p.;
Rompun, Bayer, Germany) and intracardially perfused with
0.1 M phosphate-buffered saline (PBS) followed by 4 %
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB;
pH 7.4) as fixative. Brains were removed and post-fixed in
the same fixative for 0.5–1.5 h at room temperature. After
washing, sagittal sections (50 lm thick) of the brainstem
were then cut using a vibratome (Leica Microsystems,
UK), collected in six series and stored in PBS containing
0.05 % sodium azide at 4 C.
Processing of the tissue and immunohistochemistry
Sections lateral and medial to the PPN (containing the STN
and the GiN, respectively), were collected to localize the
sites of the tracer injections under the fluorescent micro-
scope. Two series of control sections were double-immu-
nolabeled for calretinin and ChAT or calbindin and ChAT
(one series of sections for each). They were washed three
times in PBS, blocked for 1 h in normal donkey serum
(NDS; Jackson Immunoresearch Laboratories Inc., West
Grove, PA; 10 % in 0.3 % Triton X-100 in PBS) before
primary antibodies against ChAT together with antibodies
against calretinin or calbindin were added (ChAT raised in
goat, AB144P, Millipore, Temecula, CA, 1:500 dilution;
calbindin raised in mouse, CB300, Swant, Switzerland,
1:5,000 dilution; calretinin raised in rabbit, 7699/3H,
Swant, Switzerland, 1:5,000 dilution, in 1 % NDS, 0.3 %
Triton X-100 in PBS) and incubated overnight at 4 C.
They were then washed in PBS and the secondary anti-
bodies were added in NDS: donkey anti-goat-AMCA,
1:100 dilution, and either donkey anti-mouse-Cy5 1:250
dilution or donkey anti-rabbit-Cy5 (Jackson Immunore-
search Laboratories Inc) 1:250 dilution in 1 % NDS, 0.3 %
Triton X-100 in PBS and incubated at 4 C overnight.
Preliminary incubations in control and 6-OHDA-
lesioned animals were used to determine the most suitable
transcription factor to detect changes in the PPN as a
consequence of the lesion (data not shown). We incubated
with antibodies raised against Fos B (sc-48, raised in goat,
dilutions 1:250, 1:500; Santa Cruz Biotechnology, Inc.,
USA), Egr-1 (early growth response 1; sc-189, raised in
rabbit, dilutions 1:2,000, 1:2,500; Santa Cruz Biotechnol-
ogy, Inc) and phosphorylated cAMP response element-
binding (pCREB; raised in rabbit, dilutions 1:50, 1:100,
1:200, 1:500; Cell Signaling Technology, USA). The main
criteria for selection included detectable expression in the
PPN and adequate signal-to-noise ratio to allow their
quantification in retrogradely labeled neurons. Thus,
whereas the Fos B expression was adequate, but showed
low basal levels, the pCREB expression was abundant and
compromised the accurate detection in the nuclei of neu-
rons labeled with other markers. Only Egr-1 provided an
optimal signal-to-noise ratio for the purpose of this study.
Sections from control and 6-OHDA-lesioned animals,
with accurate tracer injections into the STN and GiN, were
immunolabeled to reveal Egr-1 and ChAT. One of the six
series of brain sections collected were rinsed in PBS (3
times, 10 min each) and blocked for 1 h in NDS (10 % in
PBS), before adding primary antibodies (anti-Egr-1, raised
in rabbit, Santa Cruz, 1:2,500; anti-ChAT, raised in goat,
Millipore, 1:500; in 1 % NDS in PBS, incubated overnight
at 4 C). The following day, sections were washed in PBS
then incubated overnight at 4 C in secondary antibodies
(donkey anti-rabbit-Cy5, 1:250; donkey anti-goat-AMCA,
1:100; Jackson Immunoresearch Laboratories Inc; in 1 %
NDS in PBS). They were then washed 3 times in PBS,
mounted on to slides with Vectashield mounting medium
(Vector Laboratories Inc.) and stored in the dark at 4 C
until examined. Control reactions for all the experiments
were performed by omitting each of the primary antibodies
in turn, which revealed a complete absence of fluorescence
for the omitted antibody.
Image acquisition
Immunofluorescent and retrogradely labeled neurons were
analyzed by capturing images using a LSM-710 (CarlZeiss,
Germany) confocal microscope (20 9 0.8 NA dry objec-
tive lens) with an ApoTome-structured illumination system
and using Colibri LED fluorescence as illumination source,
or an Axio Imager M2 microscope (Plan-Apochromat
20 9/0.8 M27 dry objective; Carl Zeiss, Germany). Multi-
channel stacks of images were taken in the Z-plane using a
digital camera (Axiocam HRm or HD Cam) in combination
with acquisition software Axiovision 4.8.1 (Carl Zeiss AG,
Germany). Confocal microscope images were obtained
using the ZEN software version 5.8 (Plan-Apochromat
40 9/1.3 oil DIC M27 objective). The software’s default
settings were used for filters: Ch1-T1 504, Ch2-T2 560 and
Ch3-T3 650 and the laser wavelengths were 488 nm for
green retrobeads, 543 nm for red retrobeads and 633 nm
for Cy5. The brightness and contrast of the images were
subsequently adjusted in Photoshop (Adobe Systems Inc.,
Mountain view, CA, USA).
Analysis of retrogradely labeled PPN neurons
The quantification and rostro-caudal distribution of STN-
and GiN-projecting neurons that were positive for
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calbindin and ChAT or calretinin and ChAT were analyzed
using a method based on the subdivision of the PPN into
equally spaced segments, as described previously (Mena-
Segovia et al. 2009). Using the center of the SNr, con-
centric circles at 300 lm intervals were drawn outwards to
cover the entire extent of the PPN; the first two segments
covered the SNr, then up to ten segments covered the PPN
up to its caudal extremity (from S1 to S10). The limits of
the PPN were defined by the cholinergic (ChAT-positive)
neurons, with segment S1 being the most rostral and closest
to the SNr and segment S10 being the most caudal.
Immunofluorescent and retrogradely labeled neurons
were analyzed by capturing images of the entire PPN.
Multi-channel stacks of images were taken in the Z-plane,
each separated by approximately 3 lm. For each Z-plane
level, squares of tissue were captured in the X and Y axes,
each overlapping slightly with adjacent squares, to create an
image of the whole PPN. Following the same method, low
magnification images were captured (using a 5 9 0.16 NA
dry objective) to include the entire PPN as well as the SNr.
Using the center of the SNr as a reference point, concentric
circles (330 lm apart) were drawn to delimit segments of
the PPN (see Martinez-Gonzalez et al. 2012; Mena-Segovia
et al. 2009) to allow the distributions of labeled neurons to
be analyzed using Image J software. The distances between
concentric circles were modified from previous analyses
(see Mena-Segovia et al. 2009; Martinez-Gonzalez et al.
2012) as non-dehydrated sections shrank 10–13 % less than
dehydrated sections (measurements were done in each of
the analyzed brains in the Z-plane from the top to the bottom
of the section, using Stereo Investigator software). This was
confirmed by measurements taken between the center of the
SNr and the superior cerebellar peduncle (approximately
1.9 mm lateral to Bregma; using Stereo Investigator soft-
ware). In dehydrated sections, this distance was
4,125 ± 43 lm (n = 6; Mena-Segovia et al. 2009) as
opposed to 4,659.4 ± 16.8 lm in non-dehydrated sections
(mean ± SEM; n = 3).
For the evaluation of Egr-1 labeling, the analyses were
performed as before but with a Zeiss fluorescent micro-
scope attached to a Hamamatsu digital video camera and
Stereo Investigator software. Z-plane stacks of images were
acquired at intervals of 4 lm and the use of low magnifi-
cation images to define the segments of the PPN was not
necessary. Stereo Investigator software was able to define
these segments, using the high magnification (209) ima-
ges, once the center of the SNr and the boundaries of the
PPN were specified.
Statistics
All data are presented as mean ± SEM; Student’s t test,
Rank sum Mann–Whitney and ANOVA tests were
performed using Sigma Plot software version 12.0 as
appropriate.
Results
Ascending and descending motor pathways originate
in the PPN
Neurons of the PPN have extensive axonal projections. In
some cases (e.g., cholinergic neurons), axon collaterals
from individual neurons innervate both ascending (i.e.,
forebrain, basal ganglia) and descending (i.e., lower
brainstem, medulla) targets (Mena-Segovia et al. 2008). In
contrast, non-cholinergic neurons possess only one or two
collaterals with exclusively ascending or descending pro-
jections (Mena-Segovia et al. 2008; Ros et al. 2010). In
order to determine the extent of overlap of neurons with
ascending and/or descending innervation to motor targets,
we injected retrograde tracers into the STN (red retrobeads)
and the GiN (green retrobeads) to label ascending and
descending PPN projection neurons (Fig. 1a; n = 6).
Injections in the STN covered *80 % of the nucleus
(Fig. 1b), and about 80 % of the tracer injection was
confined to the border of the nucleus in each case that was
subjected to detailed analysis. Injections in the GiN cov-
ered only a fraction of the structure (Fig. 1c) and in most
cases the totality of the tracer injection was located within
the GiN borders, as determined by the brain atlas (Paxinos
and Watson 1986), with only traces in the injection track
situated outside the border. We observed retrogradely
labeled neurons with red (STN-projecting neurons; Fig. 1d)
or green (GiN-projecting neurons; Fig. 1e) retrobeads in
the PPN 10–15 days following the tracer injections. The
borders of the PPN were defined by ChAT-expressing
neurons as described previously (Mena-Segovia et al.
2009). Retrobeads in the PPN were localized predomi-
nantly in the soma and had a distinctive punctate appear-
ance (Fig. 1d, e). A small proportion of both types of
retrobeads were detected outside the soma, presumably
corresponding to the processes of the retrogradely labeled
neurons, but the punctate pattern of expression did not
allow their characterization. Only cell bodies were con-
sidered for further analysis. The discrete localization of the
retrograde markers allowed the unequivocal detection of
double-labeled neurons (Fig. 1f).
We then analyzed the number and distribution of STN-
and GiN-projecting neurons across the rostro-caudal extent
of the PPN (Mena-Segovia et al. 2009; Martinez-Gonzalez
et al. 2012). We observed that neurons retrogradely labeled
only from the STN (STN-only; Fig. 2a) and those only
labeled from the GiN (GiN-only; Fig. 2b) have a similar,
non-uniform rostro-caudal distribution across the PPN,
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with their largest numbers in the caudal half of the nucleus
(ANOVA on ranks, Kruskal–Wallis (K–W); STN:
H9 = 41.98; GiN: H9 = 33.25; p \ 0.001; n = 6). Statis-
tical differences were mostly observed between segments
5–8 and the most rostral and caudal segments (Dunn’s test;
p \ 0.05; see Fig. 2a, b for specific comparisons). A much
lower number of neurons retrogradely labeled from
both structures (double-projecting neurons) were detected
but they were also non-uniformly distributed across the
PPN (Fig. 2c; ANOVA on ranks K–W, H9 = 25.99;
p \ 0.002; no differences were observed between specific
PPN segments, Dunn’s test; p [ 0.05). The mean total
number of neurons retrogradely labeled from the STN only
(321 ± 30) was somewhat larger that the number detected
projecting only to the GiN (200 ± 40). These differences
may relate to several factors including the site of the
deposits of retrograde tracers, the proportion of the target
structure occupied by the tracer deposits, the size/density of
the axonal fields in the STN and GiN and the activity of the
projection neurons. It is thus inappropriate to make com-
parisons between them, suffice to say that similar orders of
magnitudes of neurons project to both targets. The numbers
of neurons retrogradely labeled from both structures was
much smaller (27 ± 4). The factors listed above, as well as
topography of the projections may lead to false-negatives
and small numbers of double-labeled neurons. However,
the consistently small number of double-labeled neurons




















Fig. 1 PPN neurons project to STN and GiN. a Schematic represen-
tation showing the sites of retrobead injections (triangles). Red
retrobeads were injected in the STN and green retrobeads were
injected in the GiN. b, c Light (b) and fluorescent (c) micrographs
showing the injection sites for retrograde tracers in the STN (b) and
GiN (c; dotted lines denote STN and GiN boundaries). d–f
Fluorescent images showing a PPN neuron that projects to both the
STN and GiN (arrows) as revealed by retrograde labeling (d and e,
red and green retrobeads respectively; f merged image). DPGi dorsal
paragigantocellular nucleus, IC inferior colliculus, Pn pontine nuclei,
PnO nucleus pontis oralis, PnC nucleus pontis caudalis, scp superior
cerebellar peduncle, SNR substantia nigra pars reticulata, VPM ventral
posteromedial thalamic nucleus. Scale bars b and c: 500 lm;
d–f 10 lm
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differences in the size and/or density of collaterals in dif-
ferent structures that could lead to false negatives. These
data show that the ascending and descending PPN projec-
tions to motor structures largely originate from distinct
subsets of neurons.
Neurochemical heterogeneity of the motor output
of PPN neurons
The PPN contains subclasses of neurons that express dis-
tinct neurochemical markers. While cholinergic neurons
define the borders of the PPN itself, they account for only
about 20 % of all neurons in the PPN (Wang and Morales
2009; Mena-Segovia et al. 2009). Recently, we showed that
calbindin and calretinin are commonly expressed in PPN
neurons and their numbers are similar in magnitude to
those of the cholinergic neurons. As these calcium-binding
proteins are also expressed in GABAergic and glutama-
tergic neurons, we tested for the presence of ChAT
(Fig. 3a–d), calretinin (Fig. 3e–h) or calbindin (Fig. 3i–l)
immunoreactivity in retrogradely labeled neurons. In con-
firmation of previous work (Mena-Segovia et al. 2008), we
observed cholinergic neurons retrogradely labeled from the
STN and/or the GiN (Fig. 3a–d). Calretinin-positive neu-
rons were observed to project to both targets (Fig. 3f, g),
but immunopositive neurons projecting to both structures
were not detected (Fig. 3h), suggesting that different pop-
ulations of calretinin-expressing neurons project to the
STN and the GiN. In contrast, calbindin-positive neurons
were only observed to project to the STN (Fig. 3i–l;
n = 6). These results suggest that the PPN neurons that
innervate the STN and the GiN are neurochemically
heterogeneous.
Cholinergic neurons were the most commonly retro-
gradely labeled neurons and those projecting to the STN
(Fig. 4a) or the GiN (Fig. 4b) showed similar, non-uniform
distributions, and tended to concentrate in the caudal half of
the PPN (STN: ANOVA on ranks K–W, H9 = 22.745,
Double-projecting neuronsC
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Fig. 2 Two motor pathways originate from distinct neuronal subsets
in the PPN. a–c Histograms showing the number of neurons per PPN
segment that project to the STN (a), GiN (b), or both nuclei (c). The
neuronal populations projecting to the STN and to the GiN show
similar but heterogeneous distributions across the rostro-caudal axis
of the PPN. The greatest numbers of projection neurons per segment
were detected in S5–S8. In contrast to the single-projection neurons,
the number of double-projection neurons was considerably smaller
and did not show a significantly heterogeneous rostro-caudal distri-
bution. d Histogram showing the total number of STN-, GiN- or
double-projection PPN neurons. The number of double-projecting
PPN neurons was significantly smaller than the number of neurons
projecting to either of the targets alone. For each panel, columns
represent means, error bars indicate SEM and asterisks denote
significant differences between groups or segments (p \ 0.05; n = 6)
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p = 0.007; GiN: 1-way ANOVA, F8,18 = 3.29, p = 0.017).
However, some small differences were observed: whereas
the numbers of STN-projecting, ChAT-positive neurons
increase gradually in a rostro-caudal gradient peaking at
segment 7, the majority of GiN-projecting, ChAT-positive
neurons are concentrated in segments 5–7. The number of
double-projecting ChAT-positive neurons was much smal-
ler than the number of neurons projecting to STN-only or
GiN-only, and did not show any trend in their rostro-caudal
distribution, even though they were non-uniformly distrib-
uted (Fig. 4c; 1-way ANOVA, F8,18 = 6.11, p \ 0.001).
STN- and GiN-projecting, calcium-binding protein-positive
neurons were smaller in number and did not show a non-
uniform distribution (Fig. 4a, b). The number of STN-only
projecting neurons that express ChAT was significantly
larger than those expressing calbindin (t4 = 3.26,
p = 0.031). In addition, the number of GiN-only projecting
neurons that express ChAT were significantly larger (by a
factor of two at least) than the number of calretinin-positive
neurons projecting to the same target (t4 = 3.59,
p = 0.023). Furthermore, a significantly larger number of
ChAT-positive neurons were retrogradely labeled from the
GiN than the STN (t4 = -5.026, p = 0.007). Finally, about
a third of the double-projection neurons were cholinergic
(Fig. 4d). These results support the notion of a differential
innervation of PPN targets arising from neurochemically
distinct subpopulations of PPN neurons.
Differential regulation of PPN-projecting neurons
in Parkinsonism
The impaired activity of the PPN in PD has been associated
with some of the symptoms of the disease but the nature of
the neurons involved in these changes is not yet under-
stood. We therefore tested the basal levels of activity (i.e.
no stimulation and immediately before the activity period)
as indicated by the expression of the immediate early gene
(IEG) Erg-1, in the two motor pathways in controls and in
the 6-OHDA rat model of PD. Two–four weeks following
unilateral dopamine depletion, we injected retrobeads into
the STN and GiN. After a further 10–15 days survival, to
allow transport of the tracers, they were perfuse-fixed at the
beginning of the activity period (dark phase of the cycle)
























Fig. 3 Neurochemical heterogeneity of PPN neurons giving rise to
motor pathways. a–d Fluorescent images showing a cholinergic PPN
neuron (ChAT positive a) that projects to both the STN (b) and GiN
(c merged image in d). e–g Fluorescent images of two calretinin-
positive PPN neurons (e), one projecting to the STN (f arrow) and the
other projecting to the GiN (g arrowhead; merged image in h). i–
l Fluorescent images of a calbindin-positive PPN neuron (i) projecting
to the STN (j; merged image in l), but not to the GiN (k). Scale bars
5 lm
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retrogradely labeled PPN neurons (Fig. 5). Egr-1 immu-
nolabeling was localized in the nuclei of neurons (Fig. 5a,
f, k). Egr-1 expression was present in the PPN of control
(230 ± 86, n = 5) and 6-OHDA animals (315 ± 62,
n = 8; no statistical difference), and in a proportion of
STN-only projecting neurons (Fig. 5a–e), GiN-only pro-
jecting neurons (Fig. 5f–j) and double-projection neurons
(Fig. 5k–o). Egr-1 expression was not detected in the
nuclei of cholinergic neurons (Fig. 5d, i, n). In STN-pro-
jecting neurons, there was a significant difference in the
proportion expressing Egr-1 between control and 6-OHDA
rats (Fig. 6a; t9 = 3.599, p = 0.006; control n = 5,
6-OHDA n = 8). Thus, although low in absolute numbers,
Parkinsonian rats showed a three-fold increase in the
number of STN-only projecting neurons that are also im-
munopositive for Egr-1. In contrast, no difference was
observed between control and 6-OHDA rats in the neurons
that were retrogradely labeled from the GiN (Fig. 6b).
Furthermore, we did not detect any double-projection
neuron expressing Egr-1 in control animals. This con-
trasted with the 6-OHDA group that showed consistent
Egr-1 expression in double-projection neurons across all
animals (Fig. 6c). These data suggest that ascending and
descending pathways from the PPN are differentially reg-
ulated in the Parkinsonian rat.
Discussion
We present here evidence of two distinct, largely non-
overlapping pathways arising from the PPN that innervate
different motor structures involved in different functions.
We further show that these pathways are neurochemically
distinct and are differentially affected in the Parkinsonian
rat. Thus, PPN neurons projecting to the STN are hetero-
geneous, showing expression of ChAT, calbindin and cal-
retinin, and an increased level of activity following a
6-OHDA lesion of the SNc, as suggested by the expression
of Egr-1. In contrast, PPN neurons projecting to the GiN
are less heterogeneous, they do not express calbindin and a
larger proportion is cholinergic, but they do not show
changes in the expression of Egr-1, following a 6-OHDA
lesion. Our results provide a basis for understanding dis-
tinct motor pathways of the PPN and support a role of PPN






























































































Fig. 4 Ascending and descending motor pathways express distinct
neuronal markers. a–c Histograms showing the numbers of STN- (a),
GiN- (b) and double-projecting (c) PPN neurons that are cholinergic,
calretinin-positive or calbindin-positive, per PPN segment. Of the
single-projection neurons, only cholinergic neurons follow a similar
pattern of rostro-caudal distribution (S5–S8) for both STN- and GiN-
projecting neurons (see Fig. 2a, b). Calbindin immunoreactivity was
not detected in PPN neurons projecting to the GiN. Also evident was
the lack of calretinin and calbindin expression in double-projection
neurons. d Histogram showing the percentages of STN-, GiN- and
double-projecting PPN neurons that are cholinergic (ChAT-positive),
calretinin-positive or calbindin-positive. Only cholinergic markers,
out of the three makers tested, were detected in double-projection
neurons. For each panel, columns represent means, error bars indicate
SEM (n = 3)
1458 Brain Struct Funct (2014) 219:1451–1462
123
The motor function of the PPN
The PPN has been traditionally considered as a part of the
MLR. Early experiments showed that electrical stimulation
in the region of the PPN was able to elicit locomotion
(Skinner et al. 1990). The results of more recent studies
using more refined techniques suggest that PPN maintains a
close relationship with the MLR, and its downstream pro-
jections inhibit locomotion. Thus, through its descending
projections, mediated in part by the reticulospinal neurons
of the GiN, the effect of PPN activation would be the
















Fig. 5 Immediate early gene expression in the Parkinsonian rat. a–
e Fluorescent images showing an Egr-1-positive PPN neuron (a,
arrow) that was retrogradely labeled from the STN (b), but not the
GiN (c), and was non-cholinergic (d; merged image in e). f–
j Fluorescent images of an Egr-1-positive PPN neuron (f, arrow) that
was not retrogradely labeled from the STN (g), but was labeled from
the GiN (h; i, also non-cholinergic; merged image in j). K–O
Fluorescent images of an Egr-1-positive PPN neuron (k arrow) that
projects to both the STN (l) and GiN (m; n, also non-cholinergic;


















































Fig. 6 Differential regulation of motor pathways in the PPN of
Parkinsonian rats. a–c Histograms showing the percentages of STN-
(a), GiN- (b) and double-projection (c) PPN neurons that are Egr-1-
positive in control and 6-OHDA lesioned animals. For each panel,
columns represent means, error bars indicate SEM and the asterisk
denotes a significant difference between the control and 6-OHDA
lesioned groups for STN-projecting neurons (p = 0.006; control
n = 5; 6-OHDA n = 8)
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the modulation of the excitatory output of the MLR
(Takakusaki 2008; Takakusaki et al. 2004). On the other
hand, the PPN is known to have close interconnectivity
with many elements of the basal ganglia (Mena-Segovia
et al. 2004), including the STN (Nomura et al. 1980; Edley
and Graybiel 1983; Hammond et al. 1983). Activation of
the STN, driven at least in part by direct cortical inputs,
increases the inhibition of basal ganglia targets, mediated
by its connections with the substantia nigra pars reticulata
(SNr). Thus, an increased STN output would lead to an
increased inhibition of the reticular targets of the SNr.
In vitro experiments have shown that the overall effect of
PPN activation on STN is excitation (Hammond et al.
1983). Hence, the net effect of the ascending (activation of
the STN and basal ganglia output) and descending (acti-
vation of inhibitory spinal neurons) output of the PPN is
likely to be motor inhibition.
Based on the above rationale, and the position of the
PPN in the inhibitory output stream of the basal ganglia
(i.e., SNr), a dysfunction in the PPN output is likely to
aggravate the motor impairment in PD. Animal models of
PD have shown some degree of change in the activity of
the PPN (Nandi et al. 2002; Breit et al. 2001; Aravamuthan
et al. 2008), but the nature and causes for such changes
remain elusive. The neurochemical, electrophysiological,
topographical and functional heterogeneity of PPN neurons
(Mena-Segovia et al. 2008, 2009; Ros et al. 2010; Marti-
nez-Gonzalez et al. 2012; Wang and Morales 2009;
Boucetta and Jones 2009; Alderson et al. 2008) suggests it
is impractical to attempt to understand the output of the
PPN based simply on activation or inhibition. In the present
paper, we endeavored to take into consideration the het-
erogeneity by incorporating different variables (projection
targets, topography, neurochemical makers and level of
activity). Our findings thus support the hypothesis that
activity of different subclasses of neurons in the PPN is
differentially regulated in Parkinsonian animals.
Functionally distinct motor pathways in the PPN
Our results show that a subpopulation of PPN neurons that
have ascending projections to the STN are distinct from the
neurons that have descending projections to the GiN
(Mena-Segovia et al. 2008; Ros et al. 2010). We did not
observe a distinct topographical gradient between these
projections. This finding concurs with a previous report on
the distribution of STN-projecting neurons (Kita and Kita
2011) and suggests that the PPN projects largely separately
to these two motor structures but the projections arise from
neurons that are intermingled in the same regions of the
PPN. We have previously identified local synaptic contacts
arising from different subclasses of cholinergic and non-
cholinergic neurons within the PPN (Mena-Segovia et al.
2008; Ros et al. 2010). It is thus possible that the axon
collaterals of the projection neurons in one pathway contact
the projection neurons from the other pathway and vice
versa. When considering the heterogeneity of afferents to
the PPN that arise from diverse neuronal systems (reviewed
in Martinez-Gonzalez et al. 2011), this suggests an inte-
grative role within PPN microcircuits. In turn, the distri-
bution of cholinergic, GABAergic and glutamatergic
neurons (Mena-Segovia et al. 2009; Wang and Morales
2009; Martinez-Gonzalez et al. 2012) suggests that the
rostral PPN is predominantly inhibitory (GABAergic)
whereas the caudal PPN is predominantly excitatory
(glutamatergic). Thus, it is likely that both motor projec-
tions (i.e., STN and GiN) are predominantly glutamatergic,
and the fact that they contain a different balance of cal-
cium-binding proteins suggests that different subtypes of
glutamatergic neurons may be involved. Nevertheless, it
should be noted that a GABAergic component is also
present (Bevan and Bolam 1995).
To identify the neurochemical nature of the STN- and
GiN-projecting neurons, we used immunohistochemistry
for ChAT, calbindin and calretinin. The two calcium-
binding proteins have been shown by in situ hybridization
to be expressed in a large number of GABAergic and
glutamatergic neurons of the PPN (Martinez-Gonzalez
et al. 2012). We observed that the number of cholinergic
neurons projecting to either target was greater in the caudal
PPN compared to its rostral portion, suggesting that cho-
linergic-mediated excitation of motor structures arises
largely in the caudal PPN. Interestingly, we detected more
cholinergic neurons retrogradely labeled from the GiN than
the STN despite the fact that the tracer deposits included a
much smaller proportion of the GiN than the STN. We also
detected ChAT expression in neurons projecting to both
structures, which is consistent with the collateralization
reported in individually labeled and reconstructed neurons
(Mena-Segovia et al. 2008). About two-thirds of the dou-
ble-projection neurons were identified as non-cholinergic.
In contrast to the cholinergic neurons, calretinin-positive
neurons were observed to project to STN and GiN, but
never in the same neurons, whereas calbindin-positive
neurons were only found to project to the STN. Our find-
ings thus suggest that the output of the PPN to the STN and
GiN is highly complex and heterogeneous. Given the
caveats of false-negatives in retrograde labeling studies
(see above), our findings suggest that sub-populations of
cholinergic neurons project to either the STN or the GiN
and a sub-population projects to both structures. Similarly,
sub-populations of non-cholinergic neurons (presumably
GABAergic and glutamatergic) project to either the STN or
the GiN and sub-populations project to both structures (not
previously identified). The heterogeneity is even more
complex, not just because of their potentially GABAergic
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or glutamatergic nature, but also as consequence of the
differential expression of the calcium-binding proteins. Our
findings are largely consistent with our previous in vivo
electrophysiological characterization of cholinergic and
non-cholinergic neurons in the PPN (Mena-Segovia et al.
2008; Ros et al. 2010), although we did not detect non-
cholinergic neurons protecting to both structures. Non-
cholinergic neurons with descending projections were
shown to have distinct electrophysiological properties to
non-cholinergic neurons with ascending projections, sup-
porting the notion of functional differences between these
two pathways in normal animals (Ros et al. 2010).
Immediate early gene expression in control
and 6-OHDA lesioned rats
The analysis of the two pathways following a 6-OHDA
lesion of dopamine neurons in the SNc, showed an increase
in the number of active STN-projecting neurons, as indi-
cated by Egr-1 up-regulation. This was also most evident in
double-projection neurons, suggesting that overall, PPN
neurons with ascending projections (both STN-only and
double-projection) show Egr-1 up-regulation. Because Egr-
1 expression has been extensively associated with
increased neuronal activity (for reviews see Beckmann and
Wilce 1997; O’Donovan et al. 1999), we interpret these
findings as an increased activation of PPN neurons with
ascending projections, and consequently, an increased
synaptic drive of their target structures. Although our data
show no Egr-1 expression in cholinergic neurons, sug-
gesting that they may not be affected in this animal model,
we cannot rule out the existence of false negatives. The
difference in the expression between the ascending and
descending pathways may reflect a selective excitatory
drive of STN-projecting neurons and a potential increased
inhibition of GiN-projecting neurons (not detectable by the
basal level of IEGs expression), in agreement with the data
from other groups proposing an increased excitation (Breit
et al. 2001; Orieux et al. 2000; Barroso-Chinea et al. 2011)
or an increased inhibition (Nandi et al. 2002) in the Par-
kinsonian PPN. In this way, an imbalanced output between
the two motor pathways may underlie the gait disturbances
associated with PD.
In conclusion, our data provide evidence of functional
differences associated with distinct neuronal subtypes in
the PPN that contribute to different neuronal circuits. We
and others have proposed a functional topography in the
PPN associated with the afferent and efferent connectivity.
Here, we show evidence of functional divergence among
intermingled neurons located in the same functional
domains of the PPN. Further detailed characterization of
the neuronal circuits that constitute the PPN will be nec-
essary to understand its role in behavior and its
contribution to pathological processes that distinguish
some neurological disorders.
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